rs35313315

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004268.5(MED17):​c.1071T>A​(p.Phe357Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,832 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0080 ( 18 hom., cov: 33)
Exomes 𝑓: 0.00091 ( 11 hom. )

Consequence

MED17
NM_004268.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: -0.0160

Publications

4 publications found
Variant links:
Genes affected
MED17 (HGNC:2375): (mediator complex subunit 17) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
MED17 Gene-Disease associations (from GenCC):
  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019546747).
BP6
Variant 11-93796468-T-A is Benign according to our data. Variant chr11-93796468-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 129596.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00803 (1223/152354) while in subpopulation AFR AF = 0.027 (1121/41582). AF 95% confidence interval is 0.0256. There are 18 homozygotes in GnomAd4. There are 600 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED17NM_004268.5 linkc.1071T>A p.Phe357Leu missense_variant Exon 7 of 12 ENST00000251871.9 NP_004259.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED17ENST00000251871.9 linkc.1071T>A p.Phe357Leu missense_variant Exon 7 of 12 1 NM_004268.5 ENSP00000251871.3
ENSG00000284057ENST00000638767.1 linkc.1632T>A p.Phe544Leu missense_variant Exon 14 of 19 5 ENSP00000492220.1

Frequencies

GnomAD3 genomes
AF:
0.00803
AC:
1222
AN:
152236
Hom.:
18
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0270
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00491
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00221
AC:
556
AN:
251302
AF XY:
0.00173
show subpopulations
Gnomad AFR exome
AF:
0.0288
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000908
AC:
1327
AN:
1461478
Hom.:
11
Cov.:
31
AF XY:
0.000817
AC XY:
594
AN XY:
727054
show subpopulations
African (AFR)
AF:
0.0312
AC:
1044
AN:
33466
American (AMR)
AF:
0.00197
AC:
88
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000819
AC:
91
AN:
1111654
Other (OTH)
AF:
0.00151
AC:
91
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
73
146
219
292
365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00803
AC:
1223
AN:
152354
Hom.:
18
Cov.:
33
AF XY:
0.00805
AC XY:
600
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.0270
AC:
1121
AN:
41582
American (AMR)
AF:
0.00490
AC:
75
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68036
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
62
123
185
246
308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
2
Bravo
AF:
0.00951
ESP6500AA
AF:
0.0298
AC:
131
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00254
AC:
309
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Dec 11, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 25, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:2
Oct 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 17, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
13
DANN
Benign
0.77
DEOGEN2
Benign
0.054
.;T;.;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.73
T;T;T;T;T
MetaRNN
Benign
0.0020
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;N;.;.;.
PhyloP100
-0.016
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.26
.;N;.;.;.
REVEL
Benign
0.042
Sift
Benign
0.47
.;T;.;.;.
Sift4G
Benign
0.49
.;T;.;.;.
Polyphen
0.0010
.;B;.;.;.
Vest4
0.11
MutPred
0.24
.;Loss of methylation at K356 (P = 0.0692);Loss of methylation at K356 (P = 0.0692);.;Loss of methylation at K356 (P = 0.0692);
MVP
0.20
MPC
0.32
ClinPred
0.0032
T
GERP RS
0.092
Varity_R
0.057
gMVP
0.14
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35313315; hg19: chr11-93529634; COSMIC: COSV99074154; COSMIC: COSV99074154; API